We are here to help.

Learn more about the Depo-Provera Birth Control Injection Brain Tumor Class Action

Contact Us

or call 1 (866) 308-7722 for a free consultation.

What is Depo-Provera?

Launched in 1992, Depo-Provera by Pfizer Inc. has gained popularity as an effective and convenient birth control injection containing medroxyprogesterone, a synthetic progesterone. Administered intramuscularly every three months, it offers a long-lasting, reversible contraceptive solution for many women. Besides birth control, Depo-Provera also treats endometriosis, injected into the muscle of the upper arm or buttocks quarterly. It suppresses ovulation with a high dose of progestin. At 150 mg/mL, it's considered one of the most effective contraceptives, on par with sterilization, minimizing unintended pregnancies.

What Are the Potential Risks?

Studies suggest Depo-Provera and depo-subQ provera 104 may increase the risk of intracranial meningiomas, tumors that grow in the protective layers around the brain and the spinal cord. While these tumors are typically benign, their growth can lead to significant health issues, depending on their location and size.

Who is Included?

“Class Members” are proposed to include all women in Canada, who have taken or are currently taking Depo-Provero Birth Control Injection and have been negatively affected by the injection.

Your Class Action Lawyers